Warning Letter to TELEMED
Unspecified. See TELEMED's company page or this site's inspections.
On Nov 14, 2017, FDA's CDRH sent TELEMED a warning letter citing process validation, capa, complaint handling.
- Letter date: Nov 14, 2017
- Issued by: CDRH
- Closeout: —
The Letter
As posted on FDA.gov ↗; cited 21 CFR sections link to their page.FDA's site did not return the letter just now. Read it on FDA.gov ↗
The Firm's Other Letters
Same company or the same FDA site, newest first- TELEMEDMay 24, 2019 · CDRH
Recent Letters Citing Process validation
See them all- Sanrace Biotechnology Co., Ltd.Oct 22, 2026 · CDER · Process validation, Stability
- Bentley Laboratories LLCSep 17, 2026 · CDER · Cleaning validation, Process validation
- TCI Co., Ltd BioCosme PABP BRANCHSep 2, 2026 · CDER · Cleaning validation, Process validation
- Happy Farm Botanicals, Inc.Sep 1, 2026 · CDER · Cleaning validation, Process validation
- Jabil Inc.Aug 27, 2026 · CDER · Aseptic processing, Sterility assurance
Record
- Recipient
- Dmitry Novikov
- FDA site ID (FEI)
- 3007994837
- Cited
Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters